European tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 1.9% during the forecast period. There is impressive progress in the tuberculosis diagnostic and treatment in past decade, however, tuberculosis (TB) is still a public health concern in the European Region. Countries outside of the European Union (EU) and European Economic Area (EEA) still suffer from high rates of TB and multidrug resistant (MDR) TB, while EU/EEA countries have a significant number of TB cases among vulnerable population groups, such as people of foreign origin and prisoners. TB disease affects men more than women and those gaps in case detection and reporting are higher among men. Due to large number of TB death cases in Europe, the government are taking initiatives and including guidelines in each nation to improve the diagnostic and treatment methods across the Europe. Guidelines are predominantly available in high-income countries with established LTBI (Latent TB Infection) screening programmers. According to World Health Organization (WHO), in 2018, A total of 1.5 million people have mortality from TB (including 251 000 people with HIV). Across the globe, TB is one of the top 10 causes of mortality and the leading cause from a single infectious agent (above HIV/AIDS).

Visit for Global Tuberculosis Diagnosis and Treatment Market Report at: https://www.omrglobal.com/industry-reports/tuberculosis-diagnosis-and-treatment-market-size

European tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing. 

The key players that are active in the market include Abbott Laboratories, Becton, Dickinson and Co., BioMérieux SA, EPISTEM HOLDINGS PLC, GlaxoSmithKline PLC, Hain Lifescience GmbH, Johnson & Johnson, OTSUKA NOVEL PRODUCTS GMBH, Sandoz Inc. and Sanofi Inc.

Research Methodology

The market study of the European Tuberculosis Diagnosis and Treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. European Tuberculosis Diagnosis and Treatment  Market Research and Analysis by Drugs Type
2. European Tuberculosis Diagnosis and Treatment Market Research and Analysis by Diagnosis

The Report Covers

• Comprehensive research methodology of the European Tuberculosis Diagnosis and Treatment market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the European Tuberculosis Diagnosis and Treatment market.
• Insights about market determinants which are stimulating the European Tuberculosis Diagnosis and Treatment market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.